What should I know first?
NMDA stands for N-methyl-D-aspartate. NMDA receptors can allow electrically charged particles to pass through a cell membrane under particular conditions. They participate in synaptic communication and plasticity; they are not a diagnosis or a test for depression.
Important Distinctions
Ketamine and esketamine are NMDA receptor antagonists. Blocking this receptor is an established action, but the sequence leading to antidepressant benefit is not fully understood. A simplified diagram cannot represent every co-agonist, voltage effect or brain circuit.
Sources and References
- Ketalar: current US prescribing information (revised March 2026)
- Spravato 28 mg nasal spray: UK Summary of Product Characteristics
Product information published on the electronic Medicines Compendium (emc); supplied by pharmaceutical companies.
- Ketamine and neural changes: animal research and its limits
Article Information
- Content updated
- 2026-10-19
- Sources checked
- 2026-10-19
- Publication status
- Published

